Registry of Chronic Wounds and Ulcers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry collects structured data on patients with chronic wounds and ulcers from over 100 outpatient wound centers across the USA and Puerto Rico. The data, gathered at the point of care, includes various types of wounds such as diabetic foot ulcers, pressure ulcers, and surgical wounds. The U.S. Wound Registry, recognized as a Qualified Clinical Data Registry, aims to improve wound care quality measures and patient outcomes through comprehensive data collection and analysis. The study has been ongoing since 2005 and focuses on evaluating treatment effectiveness and adherence to established quality measures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Presence of one or more chronic wounds or ulcers of any etiology
* Wound or ulcer must be treated at a participating site (which can be a hospital outpatient department, office, mobile practitioner, in the home setting, skilled nursing, etc.)
* Care must be documented using the purpose-built, wound-specific structured electronic health record (EHR) or electronic data capture (EDC) system
* All ages, including infants and patients aged 90 years or older (reported in aggregate in accordance with HIPAA de-identification standards)
* All sexes and gender identities
* All wound types and severities, including multiple wounds per patient

Exclusion Criteria:

-None (the registry includes all eligible patients treated at participating sites without sampling or exclusion criteria)

Where it's running

• US Wound Registry
  The Woodlands, Texas, United States Recruiting

Study contacts

• Principal investigator: Caroline E Fife, MD — Intellicure LLC
• Study coordinator: Caroline E Fife, MD
• Email: cfife@USwoundregistry.com; cfife@intellicure.com
• Phone: 800-603-7896

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Multicenter test of several CAMP products plus standard care for nonhealing pressure ulcers

  This trial tests five different CAMP products added to standard care to see if they help heal nonhealing pressure ulcers in adults.

  Recruiting Phase 4 Sequence LifeScience, Inc. · North Royalton, Ohio · NCT07665268

• Evaluating human placental membrane products for treating nonhealing diabetic foot and venous leg ulcers

  This study is testing whether using human placental products along with regular care can help people with stubborn diabetic foot and leg ulcers heal better.

  Recruiting C5 Biomedical · Metairie, Louisiana · NCT06674980

• Miro3D Wound Matrix for Diabetic Foot Ulcers

  This study tests whether adding Miro3D Wound Matrix to standard care helps healing diabetic foot ulcers in adults.

  Recruiting at 6 sites Reprise Biomedical, Inc. · Phoenix, Arizona and 13 other locations · NCT07632001

• THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers

  This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.

  Recruiting Biointelligent Technology Systems SL · Barcelona · NCT07617961

• Using human placental membrane wraps with regular wound care to help heal stubborn diabetic foot and venous leg ulcers

  This trial tests whether adding one of four human placental membrane wraps to standard wound care helps people with nonhealing diabetic foot or venous leg ulcers heal faster and more completely than standard care alone.

  Recruiting Phase 4 BioLab Holdings · Philidelphia, Pennsylvania · NCT07089602

• Cellular, acellular, and matrix wound products plus standard care for nonhealing stage 3–4 pressure ulcers

  This study will try several cellular, acellular, and matrix-like wound products with standard care to see if adults with nonhealing stage 3–4 pressure ulcers heal more completely over 20 weeks than with standard care alone.

  Recruiting Phase 4 Tiger Biosciences, LLC. · Monroeville, Pennsylvania · NCT06999590

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.